Pfizer's Mylotarg Finally Gets CHMP Nod But No New Indication For Sutent
Executive Summary
The EMA is finally set to approve Pfizer's targeted anticancer Mylotarg for use in acute myeloid leukemia. The company also received opinions for Bosulif and Sutent.
You may also be interested in...
More Good News For AML As Pfizer And AbbVie/Roche Drugs Get FDA Okay
The options for AML are on the rise after no drugs for decades and the green lights for Daurismo and Venclexta mean that seven therapies for the disease have now been approved by the FDA since 2017.
More New EU Drug Approvals Bring Total For Year To 14
Seven new drugs were approved in the EU in the March-April period this year: TiGenix/Takeda's Alofisel, BioCryst's Alpivab, Chiesi's Lamzede, AstraZeneca's Lokelma, Pfizer's Mylotarg, GSK's Shingrix and MSD's Steglatro.
Six New Drugs Get EMA Nod, Radius and Portola To Fight Rejections
Two products that the European Medicines Agency this week said should not be authorized for sale in the EU are already approved in the US.